Metraipolis › archive › dc_6efb4bcf0ec9
Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42428210
- DOI
- 10.7759/cureus.110511
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T16:04:39.845Z
- SHA-256 of the archived text
e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d- Stable URL of this page
https://metraipolis.com/documento/dc_6efb4bcf0ec9
How to cite
Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210 — Europe PMC (en), https://europepmc.org/article/MED/42428210 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6efb4bcf0ec9 (Metraipolis archive dc_6efb4bcf0ec9, sha256 e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d)
BibTeX
@misc{dc6efb4bcf0ec9,
title = {Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42428210},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6efb4bcf0ec9; sha256 e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42428210. Agents can read the archived copy with the MCP tool read_document.